C-CAR011 - Cellular Biomedicine
Cellular Biomedicine: Biotech Showcase 2016 (Cellular Biomedicine Group) - Jan 30, 2016 - Anticipated initiation of P1/2b trials in multiple indications in China in H1 2016; Anticipated initiation of multicenter trial in adult B-ALL in 2016 
Anticipated new P1/2 trial • Anticipated new trial Acute Lymphocytic Leukemia • Hematological Malignancies • Oncology
http://www.cellbiomedgroup.com/investor-relations/presentations/
 
Jan 30, 2016
 
.
 
b91a6dbd-881a-4a13-9bcf-846360b31093.jpg

dd5f2ba1-28f1-4954-bbd8-14d8f1482727.jpg